Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edap Tms SA EDAP

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public... see more

Recent & Breaking News (NDAQ:EDAP)

EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results

Globe Newswire May 13, 2013

EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting

Globe Newswire May 1, 2013

EDAP Announces 23% First Quarter 2013 Revenue Growth

Globe Newswire April 11, 2013

EDAP Receives U.S. FDA Filing Acceptance of Pre-Market Approval Application

Globe Newswire March 28, 2013

EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer

Troy Schwensen March 14, 2013

EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2012 Results

Troy Schwensen March 12, 2013

EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm(R)-HIFU Pre-Market Approval Application

Troy Schwensen March 7, 2013

Break Out Stocks - Stocks Touching 52 Week Highs/Lows on Two Consecutive Days (NASDAQ: EDAP) (TSX: LGC)

Accesswire February 27, 2013

EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer

Troy Schwensen February 22, 2013

EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period

Troy Schwensen February 8, 2013

EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer

Troy Schwensen February 1, 2013

EDAP Reports 25% Year-Over-Year Revenue Growth for Fourth Quarter 2012

Troy Schwensen January 22, 2013

The Real Story Behind EDAP, VVI, CHTP and USU

Marketwired January 11, 2013

Perfect Trade Setups, How to Play CHTP, EDAP, ACAD and CHKR

Marketwired January 8, 2013

The Real Story Behind ALTE, EDAP, NEPT and PGNX

Marketwired December 20, 2012